Circulating tumor DNA to monitor metastatic breast cancer [5]

New England Journal of Medicine

Volumn 369, Issue 1, 2013, Pages 93-94

  Cristofanilli, Massimo ^a   Fortina, Paolo ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53; TUMOR MARKER; CIRCULATING TUMOR DNA; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST METASTASIS; CANCER PROGNOSIS; CIRCULATING TUMOR CELL; DNA DETERMINATION; GENETIC VARIABILITY; HUMAN; LETTER; MUTATIONAL ANALYSIS; PIK3CA GENE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SOMATIC MUTATION; TP53 GENE; TUMOR GENE; TUMOR VOLUME; ANALYTIC METHOD; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; GENE; NONHUMAN; PATIENT MONITORING; PRACTICE GUIDELINE; TREATMENT RESPONSE; TUMOR DIAGNOSIS; TUMOR XENOGRAFT;

EID: 84879774542     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1306040     Document Type: Letter

References (4)

1. Dawson S-J, Tsui DWY, Murtaza M, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013;368:1199-209.
2. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91. (Pubitemid 39095313)
3. Magbanua MJ, Sosa EV, Roy R, et al. Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res 2013;73:30-40.
4. Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339:580-4.